Intuitive is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Founded in 1995 and headquartered in the United States, the company develops, manufactures, and markets robotic-assisted surgical systems that enable surgeons to perform minimally invasive procedures with enhanced precision, control, and visualization. The company's primary products are the da Vinci surgical system and Ion endoluminal systems, both designed to give surgeons advanced tools for procedures that result in smaller incisions, reduced hospital stays, and improved patient outcomes compared to traditional open surgery.
The da Vinci surgical system represents the company's core platform in robotic-assisted surgery, providing surgeons with instrumentation and visualization capabilities for minimally invasive procedures across multiple surgical specialties. The Ion endoluminal system extends the company's technology into endoluminal applications, offering similar benefits of precision and control in a different procedural context. Both systems address the technical challenge of translating surgeon input into precise robotic motion while maintaining real-time visual feedback and control.
After nearly three decades in the field, Intuitive's systems are deployed worldwide, with millions of patients annually undergoing procedures that benefit from the company's robotic-assisted technology. The company works in deep collaboration with healthcare professionals globally to refine and advance its platforms. Current development efforts focus on making minimally invasive care more connected, customized, and intelligent, with systems designed to help physicians and care teams optimize care delivery. Under CEO David J. Rosa, the company continues to operate at the intersection of surgical robotics, medical device manufacturing, and healthcare technology systems.